IQIRVO
- Product NDC
- 15054-0080
- 11-digit product format
- 150540080
- Labeler code
- 15054
- Product ID
- 15054-0080_c77d04f1-9e73-4cde-9ab3-bac12d595fc4
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- elafibranor
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- Ipsen Biopharmaceuticals, Inc.
- Application
- NDA218860
- Marketing category
- NDA
- Marketing start
- 2024-06-10
- Substance
- ELAFIBRANOR
- Active strength
- 80 mg/1
- Pharmacologic classes
- Cytochrome P450 3A4 Inducers [MoA], Peroxisome Proliferator-activated Receptor Agonist [EPC], Peroxisome Proliferator-activated Receptor Agonists [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N218860-001 | IQIRVO | ELAFIBRANOR | 80MG | TABLET / ORAL | RLD, RS | 2024-06-10 |
Orange Book patents#
| Application-product | Patent | Expiration | Use code | Coverage / status | Submission date |
|---|---|---|---|---|---|
| N218860-001 | 11185519 | 2037-03-30 | U-3955 | 2024-06-25 | |
| N218860-001 | 11331292 | 2037-03-30 | U-1854 | 2024-06-25 | |
| N218860-001 | 11850223 | 2037-03-30 | U-1854 | 2024-06-25 | |
| N218860-001 | 11857523 | 2037-03-30 | U-3955 | 2024-06-25 | |
| N218860-001 | 12233038 | 2037-03-30 | U-1854 | 2025-03-12 | |
| N218860-001 | 12295927 | 2037-03-30 | U-1854 | 2025-06-03 | |
| N218860-001 | 12295928 | 2037-03-30 | U-1854 | 2025-06-03 | |
| N218860-001 | 12310935 | 2037-03-30 | U-1854 | 2025-06-03 | |
| N218860-001 | 12589086 | 2037-03-30 | U-4473 | 2026-04-09 | |
| N218860-001 | 12673035 | 2044-03-05 | U-1854 | Drug product | 2026-08-05 |
Orange Book exclusivity#
| Application-product | Exclusivity code | Expiration |
|---|---|---|
| N218860-001 | NCE | 2029-06-10 |
| N218860-001 | ODE-486 | 2031-06-10 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-11-14 07:37:17 | 2026-10 | N218860-001 | IQIRVO | 80MG | TABLET / ORAL | RLD, RS | 2024-06-10 | d4dbc9d85df4… | |
| 2026-10-15 13:18:30 | 2026-09 | N218860-001 | IQIRVO | 80MG | TABLET / ORAL | RLD, RS | 2024-06-10 | c2088c7a36db… | |
| 2026-09-14 22:38:34 | 2026-08 | N218860-001 | IQIRVO | 80MG | TABLET / ORAL | RLD, RS | 2024-06-10 | 84e616aacf4f… | |
| 2026-08-18 06:07:40 | 2026-07 | N218860-001 | IQIRVO | 80MG | TABLET / ORAL | RLD, RS | 2024-06-10 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | N218860-001 | IQIRVO | 80MG | TABLET / ORAL | RLD, RS | 2024-06-10 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N218860-001 | IQIRVO | 80MG | TABLET / ORAL | RLD, RS | 2024-06-10 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | N218860-001 | IQIRVO | 80MG | TABLET / ORAL | RLD, RS | 2024-06-10 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N218860-001 | IQIRVO | 80MG | TABLET / ORAL | RLD, RS | 2024-06-10 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N218860-001 | IQIRVO | 80MG | TABLET / ORAL | RLD, RS | 2024-06-10 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N218860-001 | IQIRVO | 80MG | TABLET / ORAL | RLD, RS | 2024-06-10 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N218860-001 | IQIRVO | 80MG | TABLET / ORAL | RLD, RS | 2024-06-10 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N218860-001 | IQIRVO | 80MG | TABLET / ORAL | RLD, RS | 2024-06-10 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N218860-001 | IQIRVO | 80MG | TABLET / ORAL | RLD, RS | 2024-06-10 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | N218860-001 | IQIRVO | 80MG | TABLET / ORAL | RLD, RS | 2024-06-10 | d06236e962d9… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N218860-001 | IQIRVO | 80MG | TABLET / ORAL | RLD, RS | 2024-06-10 | 79d66fd596c7… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N218860-001 | IQIRVO | 80MG | TABLET / ORAL | RLD, RS | 2024-06-10 | 301d65b070ca… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | N218860-001 | IQIRVO | 80MG | TABLET / ORAL | RLD, RS | 2024-06-10 | a50c72e98297… |
Observed Orange Book patent history#
| Captured | Edition | Application-product | Patent | Expiration | Use code | Coverage / status | Submission date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|
| 2026-11-14 07:37:17 | 2026-10 | N218860-001 | 11185519 | 2037-03-30 | U-3955 | 2024-06-25 | d4dbc9d85df4… | |
| 2026-11-14 07:37:17 | 2026-10 | N218860-001 | 11331292 | 2037-03-30 | U-1854 | 2024-06-25 | d4dbc9d85df4… | |
| 2026-11-14 07:37:17 | 2026-10 | N218860-001 | 11850223 | 2037-03-30 | U-1854 | 2024-06-25 | d4dbc9d85df4… | |
| 2026-11-14 07:37:17 | 2026-10 | N218860-001 | 11857523 | 2037-03-30 | U-3955 | 2024-06-25 | d4dbc9d85df4… | |
| 2026-11-14 07:37:17 | 2026-10 | N218860-001 | 12233038 | 2037-03-30 | U-1854 | 2025-03-12 | d4dbc9d85df4… | |
| 2026-11-14 07:37:17 | 2026-10 | N218860-001 | 12295927 | 2037-03-30 | U-1854 | 2025-06-03 | d4dbc9d85df4… | |
| 2026-11-14 07:37:17 | 2026-10 | N218860-001 | 12295928 | 2037-03-30 | U-1854 | 2025-06-03 | d4dbc9d85df4… | |
| 2026-11-14 07:37:17 | 2026-10 | N218860-001 | 12310935 | 2037-03-30 | U-1854 | 2025-06-03 | d4dbc9d85df4… | |
| 2026-11-14 07:37:17 | 2026-10 | N218860-001 | 12589086 | 2037-03-30 | U-4473 | 2026-04-09 | d4dbc9d85df4… | |
| 2026-11-14 07:37:17 | 2026-10 | N218860-001 | 12673035 | 2044-03-05 | U-1854 | Drug product | 2026-08-05 | d4dbc9d85df4… |
| 2026-10-15 13:18:30 | 2026-09 | N218860-001 | 11185519 | 2037-03-30 | U-3955 | 2024-06-25 | c2088c7a36db… | |
| 2026-10-15 13:18:30 | 2026-09 | N218860-001 | 11331292 | 2037-03-30 | U-1854 | 2024-06-25 | c2088c7a36db… | |
| 2026-10-15 13:18:30 | 2026-09 | N218860-001 | 11850223 | 2037-03-30 | U-1854 | 2024-06-25 | c2088c7a36db… | |
| 2026-10-15 13:18:30 | 2026-09 | N218860-001 | 11857523 | 2037-03-30 | U-3955 | 2024-06-25 | c2088c7a36db… | |
| 2026-10-15 13:18:30 | 2026-09 | N218860-001 | 12233038 | 2037-03-30 | U-1854 | 2025-03-12 | c2088c7a36db… | |
| 2026-10-15 13:18:30 | 2026-09 | N218860-001 | 12295927 | 2037-03-30 | U-1854 | 2025-06-03 | c2088c7a36db… | |
| 2026-10-15 13:18:30 | 2026-09 | N218860-001 | 12295928 | 2037-03-30 | U-1854 | 2025-06-03 | c2088c7a36db… | |
| 2026-10-15 13:18:30 | 2026-09 | N218860-001 | 12310935 | 2037-03-30 | U-1854 | 2025-06-03 | c2088c7a36db… | |
| 2026-10-15 13:18:30 | 2026-09 | N218860-001 | 12589086 | 2037-03-30 | U-4473 | 2026-04-09 | c2088c7a36db… | |
| 2026-10-15 13:18:30 | 2026-09 | N218860-001 | 12673035 | 2044-03-05 | U-1854 | Drug product | 2026-08-05 | c2088c7a36db… |
| 2026-09-14 22:38:34 | 2026-08 | N218860-001 | 11185519 | 2037-03-30 | U-3955 | 2024-06-25 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N218860-001 | 11331292 | 2037-03-30 | U-1854 | 2024-06-25 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N218860-001 | 11850223 | 2037-03-30 | U-1854 | 2024-06-25 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N218860-001 | 11857523 | 2037-03-30 | U-3955 | 2024-06-25 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N218860-001 | 12233038 | 2037-03-30 | U-1854 | 2025-03-12 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N218860-001 | 12295927 | 2037-03-30 | U-1854 | 2025-06-03 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N218860-001 | 12295928 | 2037-03-30 | U-1854 | 2025-06-03 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N218860-001 | 12310935 | 2037-03-30 | U-1854 | 2025-06-03 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N218860-001 | 12589086 | 2037-03-30 | U-4473 | 2026-04-09 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N218860-001 | 12673035 | 2044-03-05 | U-1854 | Drug product | 2026-08-05 | 84e616aacf4f… |
| 2026-08-18 06:07:40 | 2026-07 | N218860-001 | 11185519 | 2037-03-30 | U-3955 | 2024-06-25 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N218860-001 | 11331292 | 2037-03-30 | U-1854 | 2024-06-25 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N218860-001 | 11850223 | 2037-03-30 | U-1854 | 2024-06-25 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N218860-001 | 11857523 | 2037-03-30 | U-3955 | 2024-06-25 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N218860-001 | 12233038 | 2037-03-30 | U-1854 | 2025-03-12 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N218860-001 | 12295927 | 2037-03-30 | U-1854 | 2025-06-03 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N218860-001 | 12295928 | 2037-03-30 | U-1854 | 2025-06-03 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N218860-001 | 12310935 | 2037-03-30 | U-1854 | 2025-06-03 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N218860-001 | 12589086 | 2037-03-30 | U-4473 | 2026-04-09 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N218860-001 | 12673035 | 2044-03-05 | U-1854 | Drug product | 2026-08-05 | caaa826d4ba7… |
Observed Orange Book exclusivity history#
| Captured | Edition | Application-product | Exclusivity code | Expiration | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-11-14 07:37:17 | 2026-10 | N218860-001 | NCE | 2029-06-10 | d4dbc9d85df4… |
| 2026-11-14 07:37:17 | 2026-10 | N218860-001 | ODE-486 | 2031-06-10 | d4dbc9d85df4… |
| 2026-10-15 13:18:30 | 2026-09 | N218860-001 | NCE | 2029-06-10 | c2088c7a36db… |
| 2026-10-15 13:18:30 | 2026-09 | N218860-001 | ODE-486 | 2031-06-10 | c2088c7a36db… |
| 2026-09-14 22:38:34 | 2026-08 | N218860-001 | NCE | 2029-06-10 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N218860-001 | ODE-486 | 2031-06-10 | 84e616aacf4f… |
| 2026-08-18 06:07:40 | 2026-07 | N218860-001 | NCE | 2029-06-10 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N218860-001 | ODE-486 | 2031-06-10 | caaa826d4ba7… |
| 2026-02-19 14:30 UTC | 2026-02 | N218860-001 | NCE | 2029-06-10 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N218860-001 | ODE-486 | 2031-06-10 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N218860-001 | NCE | 2029-06-10 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N218860-001 | ODE-486 | 2031-06-10 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | N218860-001 | NCE | 2029-06-10 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N218860-001 | ODE-486 | 2031-06-10 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N218860-001 | NCE | 2029-06-10 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N218860-001 | ODE-486 | 2031-06-10 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N218860-001 | NCE | 2029-06-10 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N218860-001 | ODE-486 | 2031-06-10 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N218860-001 | NCE | 2029-06-10 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N218860-001 | ODE-486 | 2031-06-10 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N218860-001 | NCE | 2029-06-10 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N218860-001 | ODE-486 | 2031-06-10 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N218860-001 | NCE | 2029-06-10 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N218860-001 | ODE-486 | 2031-06-10 | 5bbf6a4d5a75… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N218860-001 | NCE | 2029-06-10 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N218860-001 | ODE-486 | 2031-06-10 | d8e5a09893c0… |
| 2024-10-29 15:01 UTC | 2024-10 | N218860-001 | NCE | 2029-06-10 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | N218860-001 | ODE-486 | 2031-06-10 | d06236e962d9… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N218860-001 | NCE | 2029-06-10 | 79d66fd596c7… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N218860-001 | ODE-486 | 2031-06-10 | 79d66fd596c7… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N218860-001 | NCE | 2029-06-10 | 301d65b070ca… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | N218860-001 | NCE | 2029-06-10 | a50c72e98297… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | N218860-001 | ODE-486 | 2031-06-10 | a50c72e98297… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- IQIRVO
- Listing expiration
- 2027-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| ELAFIBRANOR | 80 mg/1 |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| 2J3H5C81A5 | Internal UNII lookup |
Harmonized RxCUI identifiers#
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| d78aa14f-6ec1-4b1d-a4ae-e48658137a25 | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 5e2ac984-2d0e-4839-ace5-a37096607fe9 | Product name | 1 | 20250224 |
| 362d7abb-94e6-4c60-9a58-266894157713 | Product name | 1 | 20231023 |
| 816b97af-edc5-4060-aff1-b814bdbcad50 | Product name | 1 | 20190415 |
| 419aab54-5d5a-4146-9453-026d4a9991be | Product name | 2 | 20170525 |
| 89dac932-b90a-4410-9ab1-84c53e57de25 | Product name | 1 | 20150316 |
| d723478e-ad4a-ec23-6bd7-cfe33e1e3840 | Product name | 1 | 20140508 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 15054-0080-1 | IQIRVO | 30 in 1 BOTTLE | TABLET, FILM COATED | 30 | 3 | |
| 15054-0080-1 | IQIRVO | 1 in 1 CARTON | TABLET, FILM COATED | 1 | 3 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 15054-0080-1 | EA - Each | 15054-0080 | bfe8a945-d5b3-43c5-9e5b-d89de7eacd2c | 1 | 2024-07-12 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 15054-0080 | IQIRVO (ELAFIBRANOR) TABLET, FILM COATED [IPSEN BIOPHARMACEUTICALS, INC.] | 3 | Current NDC, 2 package rows | 20240613_d78aa14f-6ec1-4b1d-a4ae-e48658137a25.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| IQIRVO | ELAFIBRANOR | Ipsen Biopharmaceuticals, Inc. | d78aa14f-6ec1-4b1d-a4ae-e48658137a25 | 2026-08-11 | Warnings, Adverse reactions | 218860 NDA218860 15054-0080 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 2684946 | elafibranor 80 MG Oral Tablet | PSN | d78aa14f-6ec1-4b1d-a4ae-e48658137a25 | 3 |
| 2684952 | IQIRVO 80 MG Oral Tablet | PSN | d78aa14f-6ec1-4b1d-a4ae-e48658137a25 | 3 |
| 2684952 | elafibranor 80 MG Oral Tablet [Iqirvo] | SBD | d78aa14f-6ec1-4b1d-a4ae-e48658137a25 | 3 |
| 2684946 | elafibranor 80 MG Oral Tablet | SCD | d78aa14f-6ec1-4b1d-a4ae-e48658137a25 | 3 |
| 2684946 | elafibranor 80 MG Oral Tablet | SY | d78aa14f-6ec1-4b1d-a4ae-e48658137a25 | 3 |
| 2684952 | Iqirvo 80 MG Oral Tablet | SY | d78aa14f-6ec1-4b1d-a4ae-e48658137a25 | 3 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|
| 15054-0080-1 | 15054008001 | 1 BOTTLE in 1 CARTON (15054-0080-1) / 30 TABLET, FILM COATED in 1 BOTTLE | 1 bottle | 2024-06-10 | No | No | Current |